ATYR aTyr: Multiplikator Forward P/S
The upgrade of the laboratory base to expand clinical testing triggered growth, and the expected P/S ratio captured this momentum, with the current mark equal to 78.50. aTyr Pharma, Inc. (ATYR) is mitigating downtime risks by engaging external CDMO partners for protein synthesis. Further success depends on financial stability and the confirmation of safety for the therapy targeting rare lung pathologies.
Rincian metrik komprehensif lan analitis aTyr Pharmaceuticals (ATYR)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas aTyr Pharma, Inc.|ATYR - Koefisien utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas aTyr Pharma, Inc.|ATYR - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku aTyr Pharmaceuticals|ATYR - Kewajiban jangka dawa|Utang jangka cendhak perusahaan aTyr Pharma|Rasio cepet atyrpharma.com
- indikator pendapatan resik lan kelipatan nilai:
ATYR - Bathi resik|Bathi sing dikarepake aTyr Pharma, Inc.|ATYR - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep aTyr|ATYR - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA aTyr Pharmaceuticals|ATYR - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan aTyr Pharma|ATYR - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan atyrpharma.com|ATYR - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep aTyr Pharma, Inc.
- rincian pendapatan lan dodolan emiten:
Ringkesan analisis perusahaan:ATYR (aTyr Pharma)
The forward P/S ratio is used to assess the market value of aTyr Pharma, Inc. (ATYR), which is developing innovative tRNA therapy with efzofitimod. This chart compares current market capitalization with expected revenue, separating the fundamental trend from market noise and currency volatility; this allows investors to determine a fair share price relative to future cash flows from the drug's commercialization.
Pesaing langsung
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|PTGX (Protagonist Therapeutics) - Multiplikator forward rega marang pendapatan|IMVT: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan KNSA|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grifols SA GRFS|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|CLDX (Celldex Corp) - Rega forward marang dodolan|Aurinia Pharmaceuticals - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan BCRX|VERA - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan DNTH|PHVS: Multiplikator Forward P/S|AbCellera Corp - Rega forward marang dodolan|TRML (Tourmaline Bio, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S precigen.com|Rasio rega marang prakiraan pendapatan Pharming Group (PHAR)|NKTR (Nektar Therapeutics Inc) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Upstream Bio Corp UPB|ZBIO - Multiplikator forward rega marang pendapatan|Immunome, Inc. - Multiplikator Forward P/S|GOSS - Multiplikator Forward P/S|KALV (KalVista Pharmaceuticals, Inc.) - Multiplikator forward rega marang pendapatan|Septerna, Inc. - Rega forward marang dodolan|PVLA (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|Savara Pharma (SVRA) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S ATXS (Astria Therapeutics, Inc.)|ENGN - Multiplikator forward rega marang pendapatan|RAPT: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Aerovate Therapeutics Inc JBIO|ACRS: Multiplikator Forward P/S|kyvernatx.com (KYTX) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TLSA|CABA (Cabaletta Bio Inc.) - Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan VTYX (Ventyx Bio)|THTX - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Avalo Therapeutics, Inc AVTX|Rega forward marang dodolan ELDN|AGEN - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CLYM|ZURA: Multiplikator Forward P/S|Adagene Inc. - Rega forward marang dodolan|IMA (ImageneBio) - Multiplikator Forward P/S|Multiplikator Forward P/S Shattuck Therapeutics|Rasio rega marang prakiraan pendapatan Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Immunic IMUX|ATRA - Multiplikator forward rega marang pendapatan|InflaRx GmbH - Multiplikator Forward P/S|XFOR - Multiplikator Forward P/S|ACET (adicetbio.com) - Multiplikator forward rega marang pendapatan|Celularity - Rega forward marang dodolan|INMB (INmune Bio Corp) - Multiplikator Forward P/S|Barinthus Biotherapeutics Corp (BRNS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Kezar Life Sciences (KZR)|Multiplikator forward rega marang pendapatan sabbiotherapeutics.com SABS|Rasio rega marang prakiraan pendapatan Akari Therapeutics Plc AKTX|ENLV - Multiplikator forward rega marang pendapatan|QTTB: Multiplikator forward rega marang pendapatan|GOVX - Multiplikator Forward P/S|Edesa Biotech, Inc. (EDSA) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan IBIO|CARM (Carisma Therapeutics Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep XTL Biopharmaceuticals Ltd XTLB|Multiplikator Forward P/S BOLT|Multiplikator Forward P/S hcwbiologics.com (HCWB)|Aptevo Therapeutics Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake AIM (AIM ImmunoTech, Inc.)|ADTX: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep GRI Bio Inc|XORTX (XRTX) - Rasio rega marang prakiraan pendapatan|Vyome Therapeutics - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan REVB|INDP: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Scinai Immunotherapeutics Ltd. (SCNI)|CALI: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S AFMD (Affimed N.V.)|Rega forward marang dodolan ALLK|HOOKIPA - Multiplikator Forward P/S|IGMS - Multiplikator Forward P/S|iTeos Therapeutics, Inc. (ITOS) - Rasio rega marang prakiraan pendapatan|Ocean Biomedical Inc - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator forward rega marang pendapatan Third Harmonic Bio Inc (THRD)
